Canadian Cardiovascular Society Working Group: Providing a perspective on the 2007 focused update of the American College of Cardiology and American Heart Association 2004 guidelines for the management of ST elevation myocardial infarction

Welsh, Robert C.; Travers, Andrew H.; Huynh, Thao; Cantor, Warren J.

doi:10.1016/s0828-282x(09)70019-4

Cited by 28 publications

(16 citation statements)

References 55 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Many of the CVD events were treated with revascularization and antithrombotic strategies similar to those recommended in the general non‐haemophilic population (i.e. PCI with post stent antiplatelet drugs) . There were insufficient data to provide detailed information regarding type, intensity or duration of CFC prophylaxis administered during these CVD events, though the treatment of these events were relatively well tolerated with an acceptable number of major bleeding complications (Table ) and no bleeding related mortality.…”

Section: Discussionmentioning

confidence: 99%

Cardiovascular disease (CVD) in Canadians with haemophilia: Age‐Related CVD in Haemophilia Epidemiological Research (ARCHER study)

et al. 2015

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Cardiovascular disease (CVD) in Canadians with haemophilia: Age‐Related CVD in Haemophilia Epidemiological Research (ARCHER study)

et al. 2015

View full text Add to dashboard Cite

show abstract

“…74 Patients with stable angina should be assessed and managed in the same manner as patients with stable angina from atherosclerotic CAD, 75 and those with unstable symptoms managed as per existing ACS guidelines. 71,76 Patients with RIHD might also have mediastinal fibrosis, aortic calcification, valvular heart disease, pericardial disease, and cardiomyopathy. 77 Careful review of cardiac imaging is necessary to assess these concomitant lesions, because they have an important effect on the choice of coronary intervention, if needed.…”

Section: Recommendationmentioning

confidence: 99%

Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy

Virani

Dent

Brezden-Masley

et al. 2016

Canadian Journal of Cardiology

209

164

View full text Add to dashboard Cite

Modern treatment strategies have led to improvements in cancer survival, however, these gains might be offset by the potential negative effect of cancer therapy on cardiovascular health. Cardiotoxicity is now recognized as a leading cause of long-term morbidity and mortality among cancer survivors. This guideline, authored by a pan-Canadian expert group of health care providers and commissioned by the Canadian Cardiovascular Society, is intended to guide the care of cancer patients with established cardiovascular disease or those at risk of experiencing toxicities related to cancer treatment. It includes recommendations and important management considerations with a focus on 4 main areas: identification of the high-risk population for cardiotoxicity, detection and prevention of cardiotoxicity, treatment of cardiotoxicity, and a multidisciplinary approach to cardio-oncology. All recommendations align with the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system. Key recommendations for which the panel provides a strong level of evidence include: (1) that routine evaluation of traditional cardiovascular risk factors and optimal treatment of preexisting cardiovascular disease be performed in all patients before, during, and after receiving cancer therapy; (2) that initiation, maintenance, and/or augmentation of antihypertensive therapy be instituted per the Canadian Hypertension Educational Program guidelines for patients with preexisting hypertension or for those who experience hypertension related to cancer therapy; and (3) that investigation and management follow current Canadian Cardiovascular Society heart failure guidelines for cancer patients who develop clinical heart failure or an asymptomatic decline in left ventricular ejection fraction during or after cancer treatment. This guideline provides guidance to clinicians on contemporary best practices for the cardiovascular care of cancer patients.

show abstract

“…[15][16][17] The importance of developing regionalized systems is further supported by a number of national organizations in Canada and the United States. [18][19][20][21] Historically, the drivers of regionalized systems of care have been trauma and STEMI; however, other systems include stroke, traumatic brain injury (TBI) 22 , OHCA 4,23 , and burns…”

Section: Components Of Regionalized Systems Of Carementioning

confidence: 99%

The Role of EMS in Regionalized Systems of Care

Drennan

Verbeek

2015

CJEM

View full text Add to dashboard Cite

The parallel advancement of prehospital and in-hospital patient care has provided impetus for the development and implementation of regionalized systems of health care for patients suffering from acute, life-threatening injury and illness. Regardless of the patient's clinical condition, regionalized systems of care revolve around the premise of providing the right care to the right patient at the right time. Current regionalization strategies have shown improvements in the time to patient treatment and in patient outcome, with the incorporation of emergency medical services (EMS) bypass as a key component of the system of care. This article discusses the emerging role of EMS as a critical component of regionalized systems essential to ensure effective and efficient use of resources to improve patient outcome. We also examine some of the benefits and barriers to implementation of regionalized systems of care and avenues for future research.

show abstract

Canadian Cardiovascular Society Working Group: Providing a perspective on the 2007 focused update of the American College of Cardiology and American Heart Association 2004 guidelines for the management of ST elevation myocardial infarction

Cited by 28 publications

References 55 publications

Cardiovascular disease (CVD) in Canadians with haemophilia: Age‐Related CVD in Haemophilia Epidemiological Research (ARCHER study)

Cardiovascular disease (CVD) in Canadians with haemophilia: Age‐Related CVD in Haemophilia Epidemiological Research (ARCHER study)

Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy

The Role of EMS in Regionalized Systems of Care

Contact Info

Product

Resources

About